Galectin 1-A Key Player between Tissue Repair and Fibrosis

Area of Science:

• Biochemistry
• Molecular Biology
• Immunology

Background:

• Galectins are carbohydrate-binding proteins, with Galectin-1 (Gal-1) being a key member.
• Gal-1 is expressed in various tissues and plays roles in both normal physiological processes and pathological conditions.

Purpose of the Study:

• To review the dual role of Galectin-1 in wound healing, distinguishing between beneficial modulation and detrimental overexpression.
• To explore the involvement of Galectin-1 in the pathogenesis of fibrotic diseases across multiple organs.

Main Methods:

• Literature review focusing on studies investigating Gal-1's impact on wound healing phases (inflammation, proliferation, repair, re-epithelialization).
• Analysis of research on Gal-1's role in fibrotic conditions such as proliferative diabetic retinopathy, liver, renal, pancreatic, and pulmonary fibrosis.
• Examination of molecular pathways, including PI3K/Akt, implicated in Gal-1's effects.

Main Results:

• Gal-1 positively modulates distinct phases of wound healing.
• Persistent overexpression of Gal-1 promotes angiogenesis and extracellular matrix production via PI3K/Akt activation, leading to keloid formation.
• Gal-1 is implicated in the pathogenesis of diverse fibrotic diseases.

Conclusions:

• Targeted modulation of Gal-1 presents a therapeutic strategy for optimizing wound healing and preventing keloid scarring.
• Gal-1 shows promise as a diagnostic/prognostic biomarker for tissue fibrosis.
• Gal-1 represents a potential molecular target for novel antifibrotic therapies in chronic diseases.